ATE411032T1 - Verwendungen von chitosanoligosacchariden - Google Patents

Verwendungen von chitosanoligosacchariden

Info

Publication number
ATE411032T1
ATE411032T1 AT02787257T AT02787257T ATE411032T1 AT E411032 T1 ATE411032 T1 AT E411032T1 AT 02787257 T AT02787257 T AT 02787257T AT 02787257 T AT02787257 T AT 02787257T AT E411032 T1 ATE411032 T1 AT E411032T1
Authority
AT
Austria
Prior art keywords
mixtures
present
inflammation
oligosaccharide
chitosan
Prior art date
Application number
AT02787257T
Other languages
English (en)
Inventor
Isabelle Boucher
Serge Brunet
Original Assignee
Dnp Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4170829&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE411032(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dnp Canada Inc filed Critical Dnp Canada Inc
Application granted granted Critical
Publication of ATE411032T1 publication Critical patent/ATE411032T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
AT02787257T 2001-12-14 2002-12-16 Verwendungen von chitosanoligosacchariden ATE411032T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA2364924 2001-12-14

Publications (1)

Publication Number Publication Date
ATE411032T1 true ATE411032T1 (de) 2008-10-15

Family

ID=4170829

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02787257T ATE411032T1 (de) 2001-12-14 2002-12-16 Verwendungen von chitosanoligosacchariden

Country Status (10)

Country Link
US (2) US20050004057A1 (de)
EP (1) EP1455802B1 (de)
AT (1) ATE411032T1 (de)
AU (1) AU2002351583A1 (de)
DE (1) DE60229431D1 (de)
DK (1) DK1455802T3 (de)
ES (1) ES2315417T3 (de)
PT (1) PT1455802E (de)
SI (1) SI1455802T1 (de)
WO (1) WO2003051376A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1229940B1 (de) * 1999-11-15 2014-05-14 Piramal Healthcare (Canada) Limited Temperaturgesteuerte und ph-abhängige selbstgelierende biopolymere wässrige lösung
US20030158302A1 (en) * 1999-12-09 2003-08-21 Cyric Chaput Mineral-polymer hybrid composition
WO2001041822A1 (en) * 1999-12-09 2001-06-14 Biosyntech Canada Inc. Mineral-polymer hybrid composition
US20030206958A1 (en) * 2000-12-22 2003-11-06 Cattaneo Maurizio V. Chitosan biopolymer for the topical delivery of active agents
CN1471412B8 (zh) * 2000-06-29 2016-06-15 生物合成技术加拿大公司 用于修复和再生软骨和其它组织的组合物以及该组合物的用途
DE60125973D1 (de) * 2000-11-15 2007-02-22 Biosyntech Canada Inc Verfahren zur wiederherstellung einer geschädigten bandscheibe
BE1014638A6 (fr) 2002-02-12 2004-02-03 Univ Liege Methode de preparation de derives de la paroi cellulaire a partir de biomasse.
US20060141046A1 (en) * 2004-05-06 2006-06-29 Ivrea Pharmaceuticals, Inc. Particles for the delivery of active agents
EP1742612A2 (de) * 2004-05-06 2007-01-17 Ivrea Pharmaceuticals, Inc. Partikel zur wirkstofffreisetzung
WO2006054319A2 (en) * 2004-11-19 2006-05-26 Genis Ehf. Use of chitooligomer formulations to modify abnormal activity of chitinase like proteins
IS7572A (is) * 2004-11-29 2006-05-30 Genis Ehf Aðferð og efni til lækninga
DE102004060246A1 (de) * 2004-12-15 2006-07-06 Cognis Ip Management Gmbh Verwendung von Chitosan gegen Juckreiz
CA2628313A1 (en) * 2005-11-04 2007-05-31 Bio Syntech Canada Inc. Composition and method for efficient delivery of nucleic acids to cells using chitosan
WO2007113835A1 (en) * 2006-04-05 2007-10-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Anti-allergy compositions
EP2094277A4 (de) * 2006-10-20 2010-01-20 Kim Soo Youl Zusammensetzung zur behandlung von atopischer dermatitis mit glucosamin und seinen derivaten und verfahren zur behandlung von atopischer dermatitis damit
US20080182819A1 (en) * 2007-01-29 2008-07-31 Act Iii Licensing, Llc Chitosan compositions and methods for using chitosan compositions in the treatment of health disorders
EP1958639A1 (de) * 2007-02-14 2008-08-20 Polichem S.A. Verwendung von Chitosanen zur Behandlung von Entzündungserkrankungen der Nägel
EP1958638A1 (de) * 2007-02-14 2008-08-20 Polichem S.A. Verwendung von Chitosanen zum Erhöhen der Nagelwachstumsrate
DE102010020940B4 (de) * 2010-05-19 2014-09-25 Heraeus Medical Gmbh Antibiotische Beschichtung
AU2017243601A1 (en) 2016-03-30 2018-11-22 Acib Gmbh Detecting microbial infection in wounds
JP2019510036A (ja) 2016-03-31 2019-04-11 ゴジョ・インダストリーズ・インコーポレイテッド プロバイオティクス／プレバイオティクス有効成分を含む清浄剤組成物
EP3435765A1 (de) 2016-03-31 2019-02-06 Gojo Industries, Inc. Desinfektionszusammensetzung zur stimulation von antimikrobiellen peptiden
US10806769B2 (en) 2016-03-31 2020-10-20 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
US11564879B2 (en) 2016-11-23 2023-01-31 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
KR102511613B1 (ko) * 2019-09-23 2023-03-17 포항공과대학교 산학협력단 키토산을 포함하는 면역억제용 조성물 및 이의 용도
CN115996707A (zh) 2020-04-20 2023-04-21 德克萨斯大学系统董事会 生物活性干粉组合物及其制造和使用方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4532134A (en) * 1981-04-06 1985-07-30 Malette William Graham Method of achieving hemostasis, inhibiting fibroplasia, and promoting tissue regeneration in a tissue wound
CA1261264A (en) * 1984-11-29 1989-09-26 Shigeo Suzuki Immunopotentiating agents and method
IT1275198B (it) * 1992-01-16 1997-07-30 Ecobios Lab Idropittura universale, polivalente, battericida, ignifuga, traspirante ecologica, isolante, antiossidante, desalinizzante delle efflorescenze di salnitro anche di sali igroscopici per manufatti edilizi, legno, metalli e materie plastiche.
US5482843A (en) * 1992-12-14 1996-01-09 Universite De Sherbrooke Enzyme of use in chitosan hydrolysis
US5891861A (en) * 1996-10-15 1999-04-06 Platt; David Composition and method for treating fungal disease in animals
US5981510A (en) * 1997-04-15 1999-11-09 Yaizu Suisankagaku Industry Co., Ltd. Method for treating and improving diabetes
SE508760C2 (sv) * 1997-04-29 1998-11-02 Medicarb Ab Användning av en komposition innefattande kitosan i kombination med en polysackarid, som aktiv komponent i ett lösningsmedel, för framställning av ett spendoppningsmedel för mjölkproducerande djur
US5730876A (en) * 1997-05-30 1998-03-24 Hyang-Ja You Separation and purification of low molecular weight chitosan using multi-step membrane separation process
JP2001055335A (ja) * 1999-08-18 2001-02-27 Toshio Sato アレルギー性皮膚疾患治療剤
EP1127574A1 (de) * 2000-02-22 2001-08-29 Food Industry Research and Development Institute Verwendung von Chitin-enthaltenden Produkten zur Hemmung von der Erzeugung von NO
US6653294B2 (en) * 2000-02-29 2003-11-25 Food Industry Research & Development Institute Use of chitinous materials for inhibiting cellular nitric oxide production

Also Published As

Publication number Publication date
US20050004057A1 (en) 2005-01-06
EP1455802A1 (de) 2004-09-15
US20070167400A1 (en) 2007-07-19
ES2315417T3 (es) 2009-04-01
EP1455802B1 (de) 2008-10-15
SI1455802T1 (sl) 2009-06-30
DE60229431D1 (de) 2008-11-27
DK1455802T3 (da) 2009-02-16
WO2003051376A1 (en) 2003-06-26
AU2002351583A1 (en) 2003-06-30
PT1455802E (pt) 2008-11-03

Similar Documents

Publication Publication Date Title
DE60229431D1 (de) Verwendungen von chitosanoligosacchariden
CA1210699A (fr) Compositions permettant de combattre les mefaits et les inconvenients de la transpiration
EP4442241A3 (de) Retinolersatz zur hautbehandlung
WO2000051576A3 (en) Novel pharmaceuticals, dietary supplements and cosmetic compositions, and the use of certain mixtures for preparing a medicament or a dietary supplement for the treatment or prevention of inflammation, hypersensitivity reactions or pain
JP2005508936A5 (de)
BRPI0416160A (pt) composições de xampu antimicrobianas
BR9906438A (pt) Composição de reforço nutricional apropriada para o tratamento de úlceras de pressão
AU2002258066A1 (en) Dermatological and cosmetic compositions
DE60001914D1 (de) Mehrzweck zusammensetzungen von säuren
AU2002218167A1 (en) N-phenyl-2-pyrimidine-amine derivatives
CA2341973A1 (en) Antioxidant composition comprising acetyl l-carnitine and .alpha.-lipoic acid
JP2004505007A5 (de)
TW200716661A (en) A novel triterpenic acid derivative and the skin external preparation containing the same
US20020164317A1 (en) Cancer immune composition for prevention and treatment of individuals
WO2003063790A3 (en) Additives and products including oligoesters
TW200744661A (en) Topical cosmetic formulations for regulating and improving the moisture content of the skin
ZA202307290B (en) Pyrazolopyridine derivatives and uses thereof
MX9501849A (es) Nuevos compuestos biciclicos-aromaticos, composiciones farmaceuticas y cosmeticas que los contienen y sus usos.
TW200510352A (en) Cycloalkyl substituted amino acid derivatives, processes for their freparation and their use as pharmaceuticals
DE60221155D1 (de) Negatif geladene polysaccharide aus aloe vera
IL141325A0 (en) Tan-1057 derivatives
ZA201000213B (en) Chitosan carboxyalkylamide hydrogel,preparation thereof and cosmetic and dermatological use thereof
BR9708297A (pt) Compostos composição farmacéutica cosmposição e uso de uma composição cosmética
CA2491027A1 (en) Novel flavone c-glycoside derivatives and compositions containing the derivatives
WO2003002125A3 (en) Combination of aminosugars and cysteine or cysteine derivatives

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1455802

Country of ref document: EP

REN Ceased due to non-payment of the annual fee
RZN Patent revoked